Arzneiwerk AG VIDA (FRA:TLIK) Net Income From Continuing Operations : €-1.97 Mil (TTM As of Jun. 2024)

View and export this data going back to 1998. Start your Free Trial

What is Arzneiwerk AG VIDA Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Arzneiwerk AG VIDA's net income from continuing operations for the three months ended in Jun. 2024 was €-0.38 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Jun. 2024 was €-1.97 Mil.

Arzneiwerk AG VIDA Net Income From Continuing Operations Historical Data

The historical data trend for Arzneiwerk AG VIDA's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arzneiwerk AG VIDA Net Income From Continuing Operations Chart

Arzneiwerk AG VIDA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income From Continuing Operations

Get a 7-Day Free Trial

3.87

0.83

-0.27

-1.70

-1.89

Arzneiwerk AG VIDA Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Net Income From Continuing Operations	Get a 7-Day Free Trial															-0.36	-1.08	-0.29	-0.22	-0.38

Arzneiwerk AG VIDA Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.97 Mil.

Arzneiwerk AG VIDA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Arzneiwerk AG VIDA (FRA:TLIK) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

TLIK:Germany

Address

Ordensmeisterstrasse 15-16, Berlin, DEU, 12099

Website

https://www.arzneiwerk.ag

Arzneiwerk AG VIDA is active in the pharmaceutical industry. The Pharma segment combines pharmaceutical supply with a focus on digitalization and process optimization along the pharmaceutical value chains and the management of large data volumes in the pharmaceutical industry. The company focuses on the growth area of specialty pharma in Germany and Europe which usually includes high-priced drugs for chronic, complex, or rare diseases such as oncology, neurology, autoimmune diseases, ophthalmology, hemophilia, and infectious diseases.

Arzneiwerk AG VIDA Headlines

No Headlines